KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northrop Grumman (NOC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Northrop Grumman (NOC) over the last 17 years, with Q4 2025 value amounting to $4.4 billion.

  • Northrop Grumman's Cash & Equivalents rose 114.86% to $4.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.4 billion, marking a year-over-year increase of 114.86%. This contributed to the annual value of $4.4 billion for FY2025, which is 114.86% up from last year.
  • Northrop Grumman's Cash & Equivalents amounted to $4.4 billion in Q4 2025, which was up 114.86% from $2.0 billion recorded in Q3 2025.
  • In the past 5 years, Northrop Grumman's Cash & Equivalents ranged from a high of $4.4 billion in Q4 2025 and a low of $1.2 billion during Q2 2022
  • Moreover, its 5-year median value for Cash & Equivalents was $3.1 billion (2023), whereas its average is $2.9 billion.
  • In the last 5 years, Northrop Grumman's Cash & Equivalents tumbled by 7033.75% in 2022 and then skyrocketed by 18947.82% in 2023.
  • Quarter analysis of 5 years shows Northrop Grumman's Cash & Equivalents stood at $3.5 billion in 2021, then fell by 27.0% to $2.6 billion in 2022, then increased by 20.64% to $3.1 billion in 2023, then soared by 40.01% to $4.4 billion in 2024, then increased by 1.15% to $4.4 billion in 2025.
  • Its Cash & Equivalents was $4.4 billion in Q4 2025, compared to $2.0 billion in Q3 2025 and $1.9 billion in Q2 2025.